D. Mathieu et al. / Tetrahedron 60 (2004) 3855–3862
3861
1.6£1025 mol) was added and the reaction mixture was
8)/[acetonitrile/water (90/10)], gradient 20% up to 50% in
27 min) was delivered at a rate of 0.6 mL/min. Monitoring
of the column effluent was performed with a detector at 270
and 280 nm. The re0action products were compared to
authentic samples of 3 -, 40- and 5-hydroxydiclofenac kindly
provided by Ciba-Geigy (Basel, Switzerland).
analyzed by gas chromatography.
A strictly similar procedure was followed when pH buffer
was modified. In those cases, we used an acetate buffer
adjusted to pH¼4.5, a citric acid/Na2HPO4 buffer pH¼6, a
trismabase/HCl buffer pH¼8.2, a glycine/NaOH buffer
pH¼9 and a Na2HPO4/NaOH buffer pH¼11.8.
Reactions under anaerobic conditions were done by
‘freeze–thaw cycles’ of a vial containing all the reactants
except the reducing agent, and of a second vial containing
the reducing agent solution under argon. The content of the
first vial was then transferred onto the reductant solution
under argon.
References and notes
1. Meunier, B.; Robert, A.; Pratviel, G.; Bernadou, J. The
porphyrin handbook; Kadish, K. M., Smith, K. M., Guilard,
R., Eds.; Academic Press: New York, 1999; Vol. 4, p 119.
2. Mansuy, D. Coord. Chem. Rev. 1993, 125, 129.
3. Dolphin, D.; Traylor, T. G.; Xie, L. Acc. Chem. Res. 1997, 30,
251.
4.3. Hydroxylation of diclofenac
4. Costas, M.; Chen, K.; Que, L. Coord. Chem. Rev. 2000, 200–
202, 517.
The aqueous phase (1 mL) contained Fe(SO4)2(NH4)2·6H2O
(1023 M), and EDTA (8£1023 M), and 100 mg of the
sodium salt of diclofenac were added to the solution. After
2–3 h stirring at 20 8C, samples were centrifuged to
precipitate excess diclofenac, and products were analyzed
by reverse phase HPLC, as described below.
´
´
5. Menage, S.; Galey, J.-B.; Dumats, J.; Hussler, G.; Seite, M.;
Gautier Luneau, I.; Chottard, G.; Fontecave, M. J. Am. Chem.
Soc. 1998, 120, 13370.
6. Kappock, T. J.; Caradonna, J. P. Chem. Rev. 1996, 96, 2659.
7. Tsuchiya, N.; Seno, M. Chem. Lett. 1989, 263.
8. Carrier, M-N.; Sheer, C.; Gouvine, P.; Bartoli, J. F.; Battioni,
P.; Mansuy, D. Tetrahedron Lett. 1990, 31, 6645.
9. Bartoli, J. F.; Le Barch-Ozette, K.; Palacio, M.; Battioni, P.;
Mansuy, D. J. Chem. Soc., Chem. Commun. 2001, 1718.
10. Bartoli, J. F.; Lambert, F.; Morgenstern-Badarau, I.; Battioni,
P.; Mansuy, D. C.R. Chimie 2002, 5, 263.
4.4. Oxidation of anisole using 18O2
500 mL of 0.1 M phosphate buffer, containing
7.0£1027 mol of Fe(SO4)2(NH4)2, 5.6£1026 mol of
EDTA, and 1 mL of anisole were deaerated by three
freeze–thaw cycles. 1.1£1025 mol of diMeH4P were
dissolved in 200 mL of 0.1 M phosphate buffer (pH 7.4)
and deaerated by the same procedure. 18O2 was introduced
in the main vial and diMeH4P was added using a
deoxygenated syringe. After 2–3 h stirring, products were
analysed by GC–MS as described below.
11. Udenfriend, S.; Clark, C. T.; Axelrod, J.; Brodie, B. B. J. Biol.
Chem. 1954, 208, 731.
12. Hamilton, G. A. In Molecular mechanisms of oxygen
activation; Hayaishi, O., Ed.; Academic: New York, 1974;
p 405.
13. Norman, R. O. C.; Lindsay Smith, J. R. Oxidases and related
redox systems; King, T. E., Mason, H. S., Morrison, M., Eds.;
Wiley: Amherst, 1965; Vol. 1, p 131.
4.5. Oxidation of anisole using H128O
14. Ullrich, V.; Staudinger, Hj. Biological and chemical aspects of
oxygenases: proceedings; Bloch, K. E., Hayaishi, O., Eds.;
Maruzen Scientific: Tokyo, 1966; Vol. 1, p 235.
15. Metal-catalyzed oxidations of organic compounds; Sheldon,
R. A., Kochi, J. K., Eds.; Academic Press: New York, 1981.
16. Pfeiffer, S.; Mayer, B.; Hemmens, B. Angew. Chem. Int. Ed.
1999, 38, 1714.
200 mL of 0.1 M phosphate buffer (pH 7.4) containing
Fe(SO4)2(NH4)2 (1023 M, 2£1027 mol) and EDTA
(8£1023 M, 1.6£1026 mol) were lyophilized and re-dis-
solved in 200 mL of H128O. 500 mL of anisole was added in
the vial. diMeH4P (3.2£1026 mol) was introduced in the
solid state, followed by NaBH4 (1.6£1021 M,
3.2£1025 mol), added in four times. After 2–3 h, products
were analysed by GC–MS as in 18O2 experiments.
17. Hurschman, A. R.; Krebs, C.; Edmondson, D. E.; Huynh,
B. H.; Marletta, M. A. Biochemistry 1999, 38, 15689.
18. Viscontini, M.; Mattern, G. Helvet. Chim. Acta 1970, 53, 372.
19. Bernal, I.; Jensen, I. M.; Jensen, K. B.; McKenzie, C. J.;
Toftlund, H.; Tuchagues, J. P. J. Chem. Soc. Dalton Trans.
1995, 3667.
4.6. Product analysis and identification
GC analyses were done using either a packed 5% FFAP
(polar) column for anisole and benzene, or a capillary BP20
(polar) column for toluene and ethylbenzene, with detection
with a flame ionization detector (FID). The products formed
were analyzed by comparison of their retention time with
those of authentic samples and by gas chromatography-mass
spectrometry analysis using a Hewlett-Packard 5890 Series
II GC coupled with a HP5972 mass selective detector.
20. Zang, Y.; Kim, J.; Dong, Y.; Wilkinson, E. C.; Appelman,
E. H.; Que, L., Jr. J. Am. Chem. Soc. 1997, 119, 4197.
21. Artaud, I.; Ben-Aziza, K.; Mansuy, D. J. Org. Chem. 1993, 58,
3373.
22. Stotter, D. A.; Thomas, R. D.; Wilson, M. T. Bioinorg. Chem.
1977, 7, 87.
23. Mancy, A.; Antignac, M.; Minoletti, C.; Dijols, S.; Mouries,
V.; Duong, N. T.; Battioni, P.; Dansette, P. M.; Mansuy, D.
Biochemistry 1999, 38, 14264.
HPLC analyses of diclofenac metabolites were done using a
Chromatem 380 apparatus. Supernatant aliquots were
injected onto a X-terra MS C18 column (3.0£150 mm,
5 mm). The mobile phase (20 mM phosphate buffer (pH
´
24. Bort, R.; Mace, K.; Boobis, A.; Gomez-Lechon, M.-J.; Pfeifer,
A.; Castell, J. Biochem. Pharmacol. 1999, 58, 787.